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ABSTRACT 
Objective: Titanium dioxide nanoparticles (TiO2 NPs) are widely used in pharmaceutical, cosmeceutical, biomedical and industrial applications. The 
adverse effects of TiO2 NPs are also increasing alarmingly. The purpose of this study is to investigate the toxicity of TiO2 NPs on biochemical and 
histological changes in different regions of brain in adult male Wistar rats. 
Methods: Two different doses of TiO2 NPs (50 mg/kg b. w and 100 mg/kg b. w) administered orally for 14 d along with one control group, each 
group consisting of six animals. Standard biochemical methods were adopted for the estimation of enzymes alkaline phosphatase, 5’ nucleotidase, 
ATPases and gamma-glutamyl transpeptidase. Trace elements calcium, sodium, potassium and magnesium as well as metals like iron, zinc and 
copper were also estimated. 
Results: When compared with the control group, the enzymes ATPases, ALP, 5’-NT and GGT activities were significantly decreased in both the TiO2 
NPs treated groups. Ca, Na, Fe, Cu and TiO2 contents were significantly increased in both the experimental groups, while the K, Mg and Zn contents 
decreased. However, the changes in the parameters studied were more in 100 mg treated group (p<0.001) when compared to the 50 mg treated 
group (p<0.05and p<0.01). Moreover, it is also evident that different regions responded differently due to TiO2 NPs exposure. The changes were 
maximum in the cerebral hemisphere (p<0.001) followed by medulla oblongata (p<0.001) and cerebrum (p<0.05). 
Conclusion: The results clearly imply that TiO2 NPs could impair the electrochemical gradient, ionic homeostasis and membrane stability in 
different regions of the rat brain. 
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TiO2 NPs is one of the most widely applied engineered nanoparticles 
in the nanotechnology field, where it is consequently used in paints, 
paper, plastics, ceramics, toothpaste, food colorants, drug capsule, 
catalysts and wastewater treatment [1, 2]. The yearly production of 
TiO2 NPs in 2002 was approximately 3,000 tons per annum, and is 
estimated to increase to 2.5 million metric tons annually by 2025 
[3]. It is reported that in sunscreen and cosmetic products 
approximately 50% of TiO2 NPs are used [4]. It is evident from 
previous studies that less than 100 nm NPs have a high level of 
photocatalytic activity [5]. The unique characteristics of TiO2 particle 
is that it can enter the human body quickly and then imposes 
potential health risks on human [6, 7]. The adverse toxic effects of 
TiO2 NPs have been studied in several animal models like rats, mice, 
rabbits and human following exposure by multiple routes of 
administration, including whole-body exposure, dermal exposure, 
gastric lavage, and inhalation [1, 2, 8, 9]. Few studies reported that 
inhaled or injected nanoparticles enter the systemic circulation and 
migrate to various parts to exert adverse effects [10, 11].  
The effects of TiO2 NPs on hepatic and renal dysfunctions were 
demonstrated by several studies through the detection of different 
functional enzymes such as alanine aminotransferase (ALT) and aspartic 
aminotransferase (AST) [1, 12-15]. Our previous study in this laboratory 
also observed that TiO2 NPs significantly alter these enzymes affecting 
liver and kidney of rats [16]. Nanoparticles can cross the blood-brain 
barrier (BBB) and enter in the central nervous system (CNS) of the 
exposed animals [11, 17]. Dermal exposure of TiO2 NPs could penetrate 
up to the brain via the skin as it was detected in the brain of mice [18]. 
TiO2 NPs could impair the short and long-term synaptic plasticity and 
also reactive oxygen species (ROS) mediated oxidative stress-induced 
damage and inflammatory response in rat brain [19]. TiO2 NPs were also 
shown to stimulate excess ROS generation in the brain microglial cells 
and cause neuron damages [20].  
CNS is a main target for various environmental pollutants and 
xenobiotic chemicals, including heavy metals and metal oxides. 
Airborne metal dust or fumes is a foremost way of occupational 
exposure, causing acute and chronic disorders such as metal fume 
fever and chronic obstructive pulmonary disease (COPD) [21]. 
Direct disruption of neuronal cell membranes by nanoparticles 
would allow their entry into the brain [6, 21, 22]. Membrane-bound 
enzymes such as alkaline phosphatase (ALP), 5’ nucleotidase (5’-NT) 
and gamma-glutamyl transpeptidase (GGT) are predominantly 
concentrated in the vascular endothelium in the brain. Membrane 
ATPases are primary active transporters of cations that maintain a 
steep gradient and that form the basis for a range of essential 
cellular physiological processes. ATPase activity is an important 
toxicological tool to analyze the effect of xenobiotics.  
Metal ions such as calcium (Ca), sodium (Na), potassium (K), iron 
(Fe), copper (Cu), zinc (Zn) and magnesium (Mg) are vital to life and 
participate in numerous metabolic processes in every living cell with 
considerable specificity and selectivity as components of enzymes 
and other molecules complexes. These metals have to be maintained 
at a fixed level to avoid any toxic effects. Metal homeostasis 
imbalance and neuronal loss are both present in neurodegenerative 
diseases [23]. To gain new insights into the mechanisms underlying 
the brain membrane damage mediated trace metal disturbances 
caused by TiO2 NPs, this study was aimed to investigate the 
penetration of TiO2 NPs and further biochemical changes in the 
brain by administering TiO2 NPs through intragastric route to Wistar 
rats, by assessing the changes in membrane-bound enzymes, and 
trace metals in different brain regions. 
MATERIALS AND METHODS 
Chemicals and dose preparation 
TiO2 NPs (CAS NO: 13463-67-7) used in the present study was 
purchased from Sigma-Aldrich Chemicals Co. (St, Louis, MO 63103, 
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USA). The crystal profile as characterized by automatic X-ray 
diffractometer (XRD, PANlytical XPERT-PRO) equipped with 240 
mmradius goniometer. The data were collected in the mode of 
continuous scanning with a power setting of 40kV, 30 mA, scanning 
speed of 10 °/sec using Cu Kα radiation (λ=0.154 nm). TiO2 
nanoparticles were suspended in water and ultrasonicator for 5-20 
min. The suspension was dipped on the cleaned silicon wafer and 
dried in an oven at 45 °C. The morphology and particle size of TiO2 
nanoparticles were obtained with a high-resolution transmission 
electron microscopy (TEM, FEI Tecnai G2 F30S-Twin microscope). 
A 0.9 % saline solution (NaCl) was used as a suspending agent. TiO2 NPs 
suspension was prepared using physiological saline solution. The 
powdered TiO2 NPs were dispersed in the fresh sterilized physiological 
saline solution, and the suspension was ultrasonicated for 15-20 min and 
mechanically vibrated for 2-3 min to get a homogenous suspension and 
to disperse completely as much as possible. 
Animals and treatment 
Healthy adult male albino rats of Wistar strain (Rattus norvegicus) 
weighing 250-260 g obtained from the central animal house, central 
siddha research institute, Chennai were used for the present 
investigation. The animals were fed ad libitum with standard pellet 
diet and had free access to drinking water. All experimental and 
protocols described in the present study was approved by the 
institutional animal ethics committee (IAEC Approval No. 
138/PHARMA/SCRI, 2013) and are in accordance with guidelines as 
per “guide for the care and use of laboratory animals” published by 
NIH publication (NO 85-23 revised 1996) and with permission from 
committee for the purpose of control and supervision of 
experiments on animals (CPCSEA), Ministry of Social Justice and 
Empowerment, Government of India. 
Animals were randomly divided into three groups. 
Group I–Control: Rats were given a normal saline solution as vehicle 
orally by gavage, daily for 14 d. 
Group II–TiO2 NPs treatment: Rats were treated with TiO2 NPs 
dissolved in normal saline solution at a dose of 50 mg/kg body 
weight daily for 14 d, orally by gavage. 
Group III–TiO2 NPs treatment: Rats were treated with TiO2 NPs 
dissolved in normal saline solution at a dose of 100 mg/kg body 
weight daily for 14 d, orally by gavage. 
At the end of the experiment, in order to maintain comparable 
conditions blood samples are usually collected at the morning after 
an overnight fasting. The fixed time schedule eliminates the possible 
effect of diurnal variations. 24 h after the experimental period the 
animals were sacrificed by cervical decapitation. Blood was collected 
separately for serological and haematological analyses. Brain was 
removed, cleared off the adhering tissues and weighed. Brain was 
dissected out; cerebrum, cerebellum and medulla oblongata were 
separated and processed immediately for biochemical and 
histological analysis. All the biochemical estimations were carried 
out by standard spectrophotometric techniques. 
Membrane-bound enzymes assay  
The brain samples were cooled in ice-cold, 50 mmol Tris–HCl buffer 
(pH 7.55) and homogenized. The homogenate was centrifuged for 10 
min at 3000 rpm, the supernatant was used for the assay of ATPases, 
ALP, 5’-NT and GGT.  
The ATPases activity estimated according to the method of Takeo 
and Sakanashi, [24]. The activities of total, Na+/K+, Mg2+ and 
Ca2+ATPases were determined using appropriate inhibitors of ATP; 
the inorganic phosphate liberated was estimated by the method of 
Fiske and Subbarow, [25]. Appropriate standard (sodium 
dihydrogen phosphate) was also run in each batch of the assay. The 
non-specific activity was subtracted from each activity detected. The 
enzyme activity was calculated from the standard graph. The 
enzyme activity is expressed as units/mg protein. 
The activity of ALP was assayed by the method of Bessey et al. [26]. 
Each 0.5 ml reaction mixture contained 0.5 ml of glycine buffer and 
the mixture was placed in a water bath at 37 °C for 5 min. exactly 
after 30 min, the reaction was arrested by the addition of 10 ml of 
sodium hydroxide. The colour developed was read at 410 nm, in a 
spectrophotometer. 0.1 ml of concentrated HCL was added, mixed 
and the optical density was read at 400 nm. The ALP activity was 
calculated from the calibration curve obtained using para-
nitrophenol standard. ALP activity is expressed as units/mg protein. 
5’-NT was assayed following the method of Gerlach and Hiby, [27]. 
The activity of 5’-NT was measured by the selective complete 
inhibition of the enzymes by nickel ions. The assay is carried out in 
the presence and absence of nickel ions, in their presence the 
activity of nonspecific phosphatase was determined, while in their 
absence the sum of the activity of nonspecific phosphatase and 5’-NT 
was measured. The difference in the amount of phosphate ion 
liberated per unit in the two assays is a measure of 5’-NT activity 
expressed as units/mg protein. 
The GGT activity was estimated by the colorimetric method of Orlowski 
and Meister, [28]. The enzyme catalyses the transfer of γ-glutamyl 
groups from γ-glutamyl donors to the amino acids, peptide or water. The 
sample contains 0.5 ml of the substrate, 1 ml Tris-HCl buffer and 2.2 ml 
glycylglycine. 0.2 ml of enzyme solution was added to the above mixture 
then incubated. After incubation for 30 min at 37˚C, the reaction was 
arrested by the addition of 1 ml of 10% acetic acid to the test and control 
tubes. The control tubes received substrate after incubation. Standard p-
nitroaniline was also treated similarly. The amount of liberated p-
nitroaniline in the supernatant was with and without the substrate. The 
substrate incubated in the absence of enzyme under the same condition 
was used as a reference blank. The enzyme activity was expressed as 
micromoles of p-nitroaniline formed/min/mg protein of tissue extract. 
Metal content analysis 
Approximately 0.2–0.3 g of tissues were weighed, digested and 
analyzed form metal contents. Briefly, prior to elemental analysis, 
these tissues were digested with ultrapure grade nitric acid 
overnight. After adding 0.5 ml hydrogen peroxide (H2O2), the mixed 
solutions were placed at 160 °C with high-pressure reaction 
containers in an oven-chamber until the samples were completely 
digested. Then, the solutions were incubated at 120 °C to remove the 
remaining nitric acid until the solutions were colourless and clear. 
Finally, the remaining solutions were diluted to 3 ml with 2% nitric 
acid. Inductively coupled plasma-mass spectrometry (ICP-MS) 
(Agilent 7500 CE, USA) was used to determine the titanium 
concentration in the samples. Indium 20 ng/ml was chosen as an 
internal standard element. The detection limit of titanium was 0.074 
ng/ml. Data are expressed as nanograms per gram tissue. 
Histological examination 
For histology, Different brain regions were fixed for 48 h in 10% 
formalin-saline and dehydrated bypassing successfully through 
different mixtures of ethyl alcohol, cleaned in xylene and embedded 
in paraffin wax. Sections of the tissue (5–6 µm thick) were prepared 
using a rotary microtome, stained with haematoxylin and eosin 
(HandE) dye and then mounted in a neutral deparaffinized xylene 
medium for microscopic examination. 
Statistical analysis 
The data were subjected to statistical analysis using one-way 
analysis of variance (ANOVA) according to Zar, [29]. When the F test 
was found to be significant, the data were subjected to Student-
Newman-Keuls (SNK) test to assess the significance of individual 
variations between the treatment groups. 
RESULTS 
Characterization of TiO2 nanoparticles 
The microstructure, morphology, particle size and crystal profile of 
TiO2 nanoparticles were characterized by XRD and subsequent 
observation by TEM (fig. 1). The crystalline structure of TiO2 
nanoparticles is clearly evident from the observation by TEM (fig. 
1A). It is well evident from the XRD characterization the particle size 
of the TiO2 nanoparticles used in this study is having the size 33.95 
nm (fig. 1B). 
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Fig. 1: Morphology and microstructure characterized by TEM (A) and X-ray diffraction pattern (B) of TiO2 nanoparticles 
 
Membrane-bound enzymes 
Fig. 2(A) shows the activity of Ca2+ dependent ATPase in cerebrum, 
cerebellum and medulla oblongata of the control and experimental 
rats. In 50 mg TiO2 NPs exposed rat group, a major inhibition of 
Ca2+dependent ATPase activity was observed in the cerebellum 
(p<0.001) followed by medulla oblongata (p<0.01) and cerebrum 
(p<0.05). In 100 mg TiO2 NPs treated group, the activity of Ca2+ 
dependent ATPase was significantly inhibited (p<0.001) in all the 
three regions. The reduction of this enzyme due to TiO2 NPs 
exposure is more and almost same (34%) in cerebellum and 
medulla oblongata when compared to cerebrum where the 
reduction was only 27%.  
Fig. 2(B) shows the activity of Mg2+ dependent ATPase in control and 
experimental rats exposed to TiO2 NPs. The activity of Mg2+dependent 
ATPase was significantly decreased in the cerebrum (p<0.01) and 
cerebellum (p<0.05) of 50 mg TiO2 NPs treated groups whereas, no 
significant change was observed in medulla oblongata. In 100 mg 
treated group a noteworthy reduction (p<0.001) was observed in all 
the three regions. The reduction of this enzyme due to TiO2 NPs 
exposure is almost same in cerebellum and medulla oblongata (27%) 
when compared to cerebrum where the reduction was only 22%. 
  
 
Fig. 2: Activities of Ca2+ ATPase (A), Mg2+ ATPase and Na+/K+ ATPase in the cerebrum, cerebellum and medulla oblongata of rats exposed to 50 
and 100 mg/kg b. w of TiO2 NPs for 14 d. The results are expressed as mean±SEM (n = 6) per treatment and respective control groups. Levels 
of significance values are *p<0.05, **p<0.01 and ***p<0.001 compared with control group. *p<0.05 considered to be statistically significant 
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Fig. 2(C) shows the effect of TiO2 NPs on the activities of Na+/K+ 
dependent ATPase in control and experimental rat groups. In 50 mg 
exposed rats, the activity of Na+/K+ dependent ATPase was 
significantly reduced only in the cerebrum (p<0.05) and medulla 
oblongata (p<0.01), while there were no significant changes 
observed in the cerebellum. On other hand, in 100 mg administered 
group much more reduction of the activity of Na+/K+ dependent 
ATPase in the cerebellum (p<0.001) and medulla oblongata 
(p<0.001) followed by cerebrum (p<0.01) was noticed. The 
reduction of this enzyme almost same in cerebrum and cerebellum 
(37%) when compared to medulla oblongata where the decrement 
was only 27%. 
Fig. 3(A) shows the activity of ALP in the brain of rats treated with 
TiO2 NPs. The activity of ALP is significantly reduced in the 
cerebrum (p<0.01) and cerebellum (p<0.001), whereas this enzyme 
activity was unaltered in the medulla oblongata of 50 mg TiO2 NPs 
treated group. The ALP activity was further reduced in 100 mg 
treated group in all the three regions (p<0.001).  
The changes in the activity of 5’-NT of rat cerebrum, cerebellum and 
medulla oblongata is shown in fig. 3(B). In cerebrum and medulla 
oblongata regions, the activity of 5’-NT was not influenced 
significantly by TiO2 NPs in both the experimental groups. 
Interestingly, this enzyme activity was significantly decreased 
(p<0.01) in the cerebellum of 100 mg treated group. 
The result presented in the fig. 3(C) indicates the activity of GGT in 
the control and experimental rats. TiO2 NPs did not alter the GGT 
activity in medulla oblongata exposed for 50 mg treated group, 
whereas significant reduction (p<0.01) was observed in cerebrum 
and cerebellum of the same group. In100 mg TiO2 NPs exposed 
group the activity was significantly reduced in the cerebrum 




Fig. 3: Activities of ALP (D), 5’NT (E) and GGT (F) in the cerebrum, cerebellum and medulla oblongata of rats exposed to 50 and 100 mg/kg 
b. w of TiO2 NPs for 14 d. The results are expressed as mean±SEM (n = 6) per treatment and respective control groups. Levels of 
significance values are *p<0.05, **p<0.01 and ***p<0.001 compared with control group. *p<0.05 considered to be statistically significant 
 
Metal content analysis 
The contents of brain elements such as Ca, Mg, Na, K, Zn, Fe and Cu 
were determined. The contents of Ca, Mg, Na, K, Zn and Fe in rat brain 
regions are listed in table 1. It can be seen that exposure toTiO2 NPs 
has obviously changed the trace metal contents in the rat brain regions 
of cerebrum cerebellum and medulla oblongata. Increased contents of 
Ca, Na, Fe and Cu were found in different brain regions, while the 
contents of K, Mg and Zn were decreased in the same regions of brain 
from TiO2 NPs treated groups than those of the control. 
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Table 1: Effect of TiO2NPs on metal contents different regions of the adult male wistar rats 
Metal contents 
(µg/g tissue) 
Experimental groups Cerebrum Cerebellum Medulla oblongata 
Ca Control 175.40±7.57 156.80±7.08 138.70±6.94 
50 mg/kg b. w. 228.80±10.08** 189.09±9.94* 149.90±6.37 
100 mg/kg b. w. 238.20±11.78** 231.30±11.85*** 165.20±7.89* 
Na Control 167.60±7.17 156.00±5.94 137.20±5.83 
50 mg/kg b. w. 194.40±8.39* 182.70±7.15* 172.10±6.31 
100 mg/kg b. w. 203.70±8.65** 183.30±7.72* 171.20±6.79** 
K Control 2213.90±95.59 2247.50±101.50 1986.90±89.97 
50 mg/kg b. w. 1910.00±78.78* 1908.00±76.53* 1668.30±69.08* 
100 mg/kg b. w. 1903.70±78.57 1883.70±78.33* 1663.70±61.86* 
Mg Control 624.70±24.77 596.00±23.43 398.00±14.44 
50 mg/kg b. w. 608.40±22.93 499.40±21.07* 366.40±11.83 
100 mg/kg b. w. 573.80±21.07 429.90±18.54*** 365.20±12.00 
Fe Control 133.20±7.39 129.90±7.26 108.60±5.16 
50 mg/kg b. w. 164.90±7.69* 169.70±7.43** 126.90±6.96 
100 mg/kg b. w. 165.00±7.64* 171.60±7.82** 158.60±6.89*** 
Zn Control 94.40±4.53 86.20±4.29 64.60±3.66 
50 mg/kg b. w. 80.60±3.78* 71.60±3.34* 48.10±2.72** 
100 mg/kg b. w. 75.50±3.14** 70.40±2.75* 47.50±2.28** 
Cu Control 12.10±0.56 16.30±0.86 9.00±0.49 
50 mg/kg b. w. 16.10±0.74** 22.30±0.96*** 15.60±0.82*** 
100 mg/kg b. w. 19.60±0.97*** 25.00±1.04*** 15.00±0.76*** 
The results are expressed as mean±SEM (n = 6) per treatment and respective control groups. Levels of significance values are *p<0.05, **p<0.01 and 
***p<0.001 compared with control group. *p<0.05 considered to be statistically significant. 
 
Table 2: Titanium content in different regions of the rat brain after treatment 
Ti (ng/g tissue) Cerebrum Cerebellum Medulla oblongata 
Control Not detected Not detected Not detected 
50 m/kg b. w. 173.20±8.16 165.90±8.19 149.90±4.40 
100 mg/kgb. w. 225.60±12.66 221.80±11.99 160.90±6.68 
The results are expressed as mean±SEM (n = 6) per treatment and respective control groups. In control rats, titanium was not detected. 
 
 
Fig. 4: Histology of the brain tissues (cerebrum, cerebellum and medulla oblongata) in rat caused by oral administration with TiO2 NPs for 
consecutive 14 d. (A) Control g(100x) shows normal cerebral architecture; (B) 50 mg/kg b. w. TiO2 NPs group (100x): arrow indicates 
calcification deposition in neurocyte; suggesting too much of calcium depositing and accumulating in the cerebrum; (C) 100 mg/kg b. w. 
TiO2 NPs group (100x): arrow indicates ependyma proliferation; (D) control group (100x) shows normal cerebellum architecture and 
covering meninges (m); (E) 50 mg/kg b. w. TiO2 NPs group (100x): arrow indicates congestion and oedema in meninges covering the 
cerebellum; (F) 100 mg/kg b. w. TiO2 NPs group (100x): arrow indicates degeneration in purkinje cells; (G) control group (100x) shows 
normal medulla oblongata architecture; (H) 50 mg/kg b. w. TiO2 NPs group (100x): arrow indicates Axonal dystrophy, suggesting 
pathological changes of the neuron; (I) 100 mg/kg b. w. TiO2 NPs group (100x): arrow indicates Focal hemorrhage in the medulla 
oblongata. The section was stained with H and E and examined by light microscopy 
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The content of titanium in the rat brain regions are shown in table 2. 
With the increasing doses of TiO2 NPs, the titanium accumulation in 
cerebrum, cerebellum followed by medulla oblongata was elevated 
in both the groups, but not detected in control group. 
Histology observations of the brain regions  
Different regions of the brain histological pictures are illustrated in 
fig. 4. In the 50 and 100 mg/kg b. w. TiO2 NPs treated groups, the 
brain tissues had abnormal pathological changes compared with the 
control, suggesting calcification of neurocyte in the cerebrum, which 
is a result of too much Ca depositing and accumulating in the brain, 
the proliferation of ependyma and spongiocyte, respectively (fig. 4B, 
E and F). The generation of calcification and Ca depositions is 
confirmed by the assay of Ca content of brain regions. 
DISCUSSION 
Most toxicants interact with intracellular target molecules to cause 
changes in cellular metabolism and function, which eventually lead 
to cell membrane damage and cell lysis. Metal-induced plasma 
membrane damage occurs directly through interaction with 
membrane components such as ion-dependent ATPases and ion 
channels, and indirectly as a consequence of cytosolic damage [30]. 
The role of Mg2+ ATPase is to maintain the high intracellular Mg2+ level 
in brain, changes of which can alter the rate of protein synthesis and 
cell growth [31]. Mg2+ -ATPase is involved in ATP synthesis through 
oxidative phosphorylation in mitochondria [32]. The observed 
decrease in activity of Mg2+ ATPase in may hamper the ATP synthesis 
and thus can lead to mitochondrial disorganization [33].  
Ca2+ ATPase, a Ca2+ binding protein and being crucial for maintenance of 
neuronal Ca2+ homeostasis [34], was significantly inhibited when 
exposed to TiO2 NPs. Calcium signalling is used by neurons to control a 
variety of functions, including cellular differentiation, synaptic 
maturation, neurotransmitter release, intracellular signalling, and cell 
death [35]. Ca2+ -ATPase is a Ca2+ pump that transfers Ca2+ from the 
cytosol to the lumen of the endoplasmic reticulum at the expense of ATP 
hydrolysis. Therefore, it regulates the intracellular Ca2+ and, in turn, 
numerous cellular processes, such as exocytosis, cell proliferation, gene 
transcription, muscle contraction, and cell survival [36].  
Na+-K+ -ATPases play an important role in epithelial cell interaction and 
pathologies related with polarized epithelial cells and malignant tumors 
[37]. Na+/K+ -ATPase is a key enzyme implicated in neural excitability, 
metabolic energy production [37]. This enzyme has a fundamental role 
in the regulation of epithelial cell morphology, signal transduction, and 
cell signalling [38]. Na+/K+ -ATPase activity significantly decreased in the 
brain of TiO2 NPs treated mice and it was suggested that Na+/K+ -ATPase 
could not export intracellular redundant Na+ and/or import extracellular 
K+ timely. Decreased activity of Na+/K+ -ATPase activity in the brain of 
TiO2 NPs exposed rats, may reduce Na+ and K+ electrochemical gradient, 
disturbed ionic homeostasis and impair the physiological functions of 
neurons. In the present study, the altered activities of enzyme which are 
major biochemical component of cell membrane is suggestive of altered 
cellular proliferation and movement. It has been reported that metals 
interferes with the cell proliferation and cell migration [39].  
ALP plays a crucial role in the metabolism of the CNS. ALP is 
associated with transmembrane transport mechanism, ion 
transport, maintenance of ionic strength and epithelial cell growth, 
differentiation and secretary activities [40]. ALP activity changes 
relatively under pathological conditions. In experimental brain 
wounds, high enzyme activity was reported in reorganizing 
capillaries at the borders of the lesion, in microglia cells, and in 
amorphous material within the brain wound [41]. It has been shown 
that the ALP is involved in the mediation of membrane transport 
and transphorylation [42]. The altered activity of ALP observed in 
the brain of TiO2 NPs treated rats suggests cell damage in the brain. 
The decrease in the activity of ALP in the present study by 
administration of TiO2 NPs could be attributed to either leakage of 
the enzyme into the extracellular fluid as a result of the disruption of 
the ordered lipid bilayer of the membrane or inhibition of the 
enzyme activity.  
5'-NT is an established plasma membrane marker enzyme in many 
mammalian cells where it exists as an ectoenzyme [43]. The enzyme 
activity controls intracellular levels of nucleoside 5’ mono-
phosphates, and it is a major contributor to the cascade that 
completely hydrolyze extracellular ATP to adenosine, and thus of 
major pharmacological interest. Reduction in the activity of 5'-NT 
was found in metal-treated group compared to control group [44]. 
The inhibition of 5′-NT due to TiO2 exposure may result in a 
decrease in extracellular adenosine production. 
GGT is also considered as a marker enzyme of cell membrane. GGT 
couples γ-glutamyl moiety to a suitable amino acid acceptor for 
transport into the cell and makes it suitable for the intracellular 
synthesis of GSH. GGT also mediates the cleaving of the dipeptidyl 
cysteinyl glycine, which provides cells with cysteine, a rate-limiting 
factor for the synthesis of GSH [45]. 
Trace elements are essential for normal brain structure and 
functions. Tiny amounts of these elements help in the formation of 
neurotransmitters and involved in the antioxidant defence and 
intracellular redox regulation and modulation of neural cells [46]. In 
the present study, TiO2 NPs treatment increased Ca content in brain 
regions, which was consistent with the histological observation of 
the brain tissues. Brain injury involving in calcification and calcium 
deposition in neurocytes of TiO2 NPs exposed rats, which may 
indirectly or directly disturb the homeostasis of trace elements in 
brain as already suggested by Hu et al. [4]. Deficiency or excess of 
these metals resulted in central nervous system disorders [47] and 
pathological situation of the brain, such as neuronal injury, 
neurodegenerative diseases, and brain ischemia [48].  
The present study shows the increased Ca and decreased Zn levels in 
various brain regions of rats exposed to TiO2 NPs. Thilsing-Hansen and 
Jørgensen, reported the antagonism between Ca and Zn in the brain 
following oral administration of ZnO NPs [49]. In the present study also 
TiO2 NPs shows the antagonism between Ca and Zn in different regions 
of the brain. The changes in the Ca and Zn content caused by TiO2 NPs 
can disturb the ion homeostasis and cause a series of physiological 
disorders in the CNS as it has been suggested earlier [34]. 
Fe as an important trace element is essential for neuron 
development and function. It is required for various physiological 
events including mitochondrial respiration, oxygen transport and 
DNA synthesis [50]. Furthermore, iron contributes to oxidative 
stress through Fenton reaction, leading to damages in DNA, proteins 
and membranes [51]. Fe imbalance is a precursor to the 
neurodegenerative processes leading to Alzheimer’s disease (AD) 
and quantification of brain Fe content can be an effective marker for 
early diagnosis of AD [51]. In the present study, TiO2 NPs treatment 
increased Fe content in different regions of rat brain. Excessive Fe 
would induce cell injury by reacting with H2O2 to produce hydroxyl 
radical (OH−), superoxide anions (O2−), and ROS [53]. The Fe 
overload in the brain may lead to neuron damage [54]. Fe is 
necessary in many cellular functions, especially in the brain, where it 
participates in many neuronal processes. In excess Fe is toxic to 
cells. The brain continuously accumulates Fe, resulting in increased 
iron storage within the cell. This effect may lead to oxidative stress. 
Zn is the second most abundant transition metal in the body [55], 
which is involved in the protection of BBB against oxidative stress of 
free radicals and essential for the synthesis of more than 300 
coenzymes or metaloproteins that mediate biogenic amines 
synthesis and metabolism [56]. Zn level is essential to maintain 
homeostasis within the brain and prevent the development of 
neurological disorders [48]. A reduction in brain Zn content can 
impair the spatial memory in adult rats [57]. The observed 
reduction in the Zn content in different regions of the brain by TiO2 
NPs may affect the function of Zn containing glutaminergic neurons 
and impairment of learning ability. This suggestion has already been 
put forth by Hu et al. in mice [4]. 
Cu is essential for normal CNS development and function, an 
essential cofactor in numerous enzymes, including cytochrome-c-
oxidase (CcO), Cu/Zn superoxide dismutase (Cu, Zn-SOD) and 
ceruloplasmin (Cp) that play a central role for controlling the 
homeostasis of neurotransmitter and basic brain function [58]. The 
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observed increased Cu level in the present study may disrupt the 
homeostasis in the brain and adverse effects in different regions of 
brain as it has also been shown in Fe2O3 NPs administered rats [59]. 
These findings support the hypothesis that neuronal cells from the 
brain regions of TiO2 NPs exposed rats undergo oxidative stress, 
which could ultimately lead to neurotoxicity as also suggested 
earlier [4, 60, 61]. The changes in electrochemical gradient and ionic 
homeostasis clearly indicate the damage to the brain of rats exposed 
to TiO2 NPs subsequently affecting the CNS. 
Metals primarily affect the mammalian brain and it has the capacity 
to damage the developing as well as the mature brain. The exact 
chemical mechanism by which TiO2 NPs influences brain is not clear. 
From this study, it is evident that TiO2 NPs have a definite influence 
on membrane-bound enzymes and trace metals in the brain of male 
rats. The altered biochemical parameters strongly suggest the 
alteration in cell permeability, and possible cell injury and damage 
to CNS. 
CONCLUSION 
Our results clearly imply that orally ingested TiO2 NPscould impair 
the electrochemical gradient, ionic homeostasis and membrane 
stability in different regions of the rat brain. These changes may 
definitely have an adverse impact on CNS and associated functions. 
However, further approach at the molecular level is in progress 
which will through more light on this aspect. 
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